Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease.
Moderna Inc. (MRNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 18,000 | $2,137,500 | -32% | 0.68% | |
| 2. | 13,500 | $1,603,125 | -62% | 0.51% | |
| 3. | CaaS Capital Frank Fu | 3,308 | $392,825 | +11% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.00 | 52,631 | Director | 420,407 | 2020-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $124.61 | 700 | 2,254,015 | 2024-07-17 | Filing | ||
| $123.82 | 6,699 | 2,254,715 | 2024-07-17 | Filing | ||
| $122.86 | 2,900 | 2,261,414 | 2024-07-17 | Filing | ||
| $121.57 | 2,100 | 2,264,314 | 2024-07-17 | Filing | ||
| $120.86 | 2,601 | 2,266,414 | 2024-07-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 45,654,527 | $4,540,342,711 | 3.74% | |
| 2. | 33,907,072 | $3,372,058,312 | 0.07% | |
| 3. | 25,301,692 | $2,516,253,271 | 0.06% | |
| 4. | 14,623,723 | $1,454,329,252 | 0.07% | |
| 5. | 9,666,038 | $961,287,479 | 72.53% |
News See All
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...
Jim Cramer's 10 Stock Picks Heading Into June
Jim Cramer in a latest program lamented over Salesforce's latest declines following the company's weak Q1 results and guidance cut.
Jim Cramer's Latest Stock Picks in May 2024
Jim Cramer on Friday analyzed the market rally following the latest CPI data which showed inflation was easing in April.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56.
5 Cathie Wood Stocks Insiders are Selling
Moderna Inc (NASDAQ:MRNA) ranks fifth in our list of the stocks in Cathie Wood's portfolio seeing insider selling.
5 Biggest Biotechnology Companies in the World
Argenx SE (NASDAQ:ARGX), based in the Netherlands, is one of the biggest biotechnology companies in the world known for its innovative immunology solutions.
5 Biotech Stocks with Huge Potential
In this article, we will take a look at the 5 biotech stocks with huge potential.
Cathie Wood Was Buying These 5 Stocks for 2024
Cloud-based restaurant management software company Toast Inc (NYSE:TOST) ranks fifth in our list of the top Cathie Wood stock picks in 2024.
Billionaire Hedge Funds
